Monitoring the efficacy of specific treatment in chronic Chagas disease by polymerase chain reaction and flow cytometry analysis

Parasite

Volumn 12, Issue 4, 2005, Pages 353-357

  Sanchez G ^a,c   Coronado, X ^a   Zulantay, I ^a   Apt, W ^a   Gajardo, M ^b   Solari, S ^a   Venegas, J ^a  

^a Facultad de Medicina   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Chronic Chagas disease; Flow cytometry anti live trypomastigote antibodies (FC ALTA); Polymerase chain reaction (PCR)

Indexed keywords

EID: 29144536153     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: 10.1051/parasite/2005124353     Document Type: Article

References (17)

1. APT W., ARRIBADA A.., ZULANTAY I., SÁNCHEZ G., VARGAS S.L. & RODRÍGUEZ J. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during nine years of follow-up. Annals of Tropical Medicine and Parasitology, 2003, 97, 23-29.
2. BRITTO C., CARDOSO M.A., MONTEIRO VAN C.M., HASSLOCHER-MORENO A., XAVIER S.S., OELEMAN W., SANTORO A., PIRMEZ C., MOREL C. & WINCKER P. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples for diagnosis and treatment evaluation. Parasitology, 1995, 110, 241-247.
3. BRITTO C., SILVEIRA C., CARDOSO M.A., MARQUES P., LUQUETTI A., MACEDO V. & FERNÁNDEZ O. Parasite persistence in treated chagasic patients revealed by xenodiagnosis and polymerase chain reaction. Memórias Instituto Oswaldo Cruz, 2001, 96, 823-826.
4. CHIARI E. Chagas disease diagnosis using polimerase chain reaction, hemoculture and serologic methods. Memórias Instituto Oswaldo Cruz, 1999, 94 (Suppl.), 299-300.
5. DE CASTRO A.M., LUQUETTI A.O., RASSI A., RASSI G.G., CHIARI E. & GALVAO L.M.C. Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi. Parasitology Research, 2002, 88, 894-900.
6. GALVAO L.M., NUNES R.M., CANCADO J.R., BRENER Z. & KRETTLI A.U. Lytic antibody title as a means of assessing cure alter treatment of Chagas disease: a 10 years follow-up study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993, 87, 220-223.
7. MARTINS-FILHO O., PEREIRA M.E.S., CARVALHO J.F., CANCADO J.R., RASSI A. & BRENER Z. Flow cytometry: a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas disease. Clinical and Diagnostic Laboratory Immunology, 1995, 5, 569-573.
8. MARTINS-FILHO O., ELOI-SANTOS S.M., TEIXEIRA A., CORREA R., RASSI A., OSTEMAYER A., RASSI G.G. & BREMER Z. Double-blind study to evaluate flow cytometry analysis of anti-live trypomastigote antibodies for monitoring treatment efficacy in cases of human Chagas' disease. Clinical and Diagnostic Laboratory Immunology, 2002, 5, 1107-1113.
9. RODRÍGUEZ COURA J. & DE CASTRO S.L. A critical Review on Chagas disease Chemotherapy. Memórias Instituto Oswaldo Cruz, 2002, 97, 3-24.
10. SAIKI R.K., SCHARF S., FALOONA F., MULLIS KB., HORN GT., ERLICH HA. & ARNHEIM N. Enzymatic amplification of β-globin sequences and restriction site analyses for diagnosis of sickle cell anemia. Science, 1985, 230, 1350-1354.
11. SÁNCHEZ G., ZULANTAY I., VENEGAS J., SOLARI A., GÁLVEZ R., PEÑA P., RODRÍGUEZ J. & APT W. Treatment with allopurinol and itraconazol changes lytic activity in patients with chronic, low grade Trypanosoma cruzi infection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995, 89, 438-439.
12. SCHENONE H. Xenodiagnosis. Memórias Instituto Oswaldo Cruz, 1999, 94, 289-294.
13. SOLARI A., ORTIZ S., SOTO A., ARANCIBIA C., CAMPILLAY R., CONTRERAS M., SALINAS P., ROJAS A. & SCHENONE H. Treatment of Trypanosoma cruzi-infected children with nifurtimox: a three year follow-up by PCR. Journal of Antimicrobial Chemotherapy, 2001, 48, 515-519.
14. WALLACE A., ORTIZ S., SANCHEZ G., VILLAGRA R., MUGA M. & SOLARI A. Studies on parasitemia courses and mortality in mice infected with genetically distant Trypanosoma cruzi clonets. Biological Research, 2001, 34 (2), 83-90.
15. WORLD HEALTH ORGANIZATION. Chagas disease interrupted in Chile. TDR News, 2000, 61, 10.
16. WINCKER P., BOSSENO N.F., BRITTO C., YAKSIC N., CARDOSO N.A., MOREL C.M. & BRENIERE S.F. High correlation between Chagas disease serology and PCR-based detection of Trypanosoma cruzi kinetoplast DNA in Bolivian children living in a edemic area. FEMS. Microbiology Letters, 1994, 124, 419-424.
17. ZULANTAY I., HONORES P., SOLARI A., APT W., ORTIZ S., OSUNA A., ROJAS A., LÓPEZ B. & SÁNCHEZ G. Use of polymerase chain reaction (PCR) and hybridization assays to detect Trypanosoma cruzi in chronic chagasic patients treated with itraconazole or allopurinol. Diagnostic Microbiology and Infectious Disease, 2004, 48, 253-257.